# OnCo record idea-fund-implementation-quota (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-fund-implementation-quota/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-fund-implementation-quota" ;
  schema:name "A fixed share of trial-group funding for getting proven care to patients"@en ;
  schema:description "Proven treatments, genomic tests and timely referrals routinely fail to reach the patients who qualify for them. Public trial networks such as the NCTN groups, EORTC and the UK NIHR portfolio would have to spend at least 10% of their funding on cluster-randomised or stepped-wedge trials of how to close that gap, cheap studies that use routine data."@en ;
  schema:url <https://onco.cc/ideas/idea-fund-implementation-quota/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1186/1471-2407-12-526> ;
  onco:related <https://onco.cc/collections/nccn/>, <https://onco.cc/collections/esmo-guidelines/>, <https://onco.cc/ideas/idea-fund-payer-funded-pragmatic-trials/> ;
  onco:technologies <https://onco.cc/technologies/geriatric-assessment/>, <https://onco.cc/technologies/cgp/> ;
  onco:companies <https://onco.cc/companies/swog/>, <https://onco.cc/companies/ecog-acrin/>, <https://onco.cc/companies/curie-nki-eortc/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-funding-allocation/>, <https://onco.cc/bottlenecks/b-care-fragmentation/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-sun-bmc-cancer/> .